These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3520996)

  • 21. The value of serial serum trough cyclosporine levels in human renal transplantation.
    Kahan BD; Wideman CA; Reid M; Gibbons S; Jarowenko M; Flechner S; Van Buren CT
    Transplant Proc; 1984 Oct; 16(5):1195-9. PubMed ID: 6385376
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of erythromycin on blood cyclosporine concentrations in kidney transplant patients.
    Ben-Ari J; Eisenstein B; Davidovits M; Shmueli D; Shapira Z; Stark H
    J Pediatr; 1988 Jun; 112(6):992-3. PubMed ID: 3286858
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporine in the treatment of acute allograft rejection refractory to high-dose methylprednisolone: results of a prospectively randomized trial.
    Margreiter R; Lang A; Koenig P; Kathrein H; Spielberger M; Steiner E; Huber C
    Transplant Proc; 1984 Oct; 16(5):1202-4. PubMed ID: 6385378
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heart transplantation].
    Hetzer R; Warnecke H; Schüler S; Süthoff U; Wonigeit K; Lang W; Herrmann G; Hepp A; Schaps D; Borst HG
    Internist (Berl); 1985 Sep; 26(9):563-8. PubMed ID: 3905678
    [No Abstract]   [Full Text] [Related]  

  • 26. Late rejection in patients receiving cyclosporine.
    Johnson HK
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):197-203. PubMed ID: 3515688
    [No Abstract]   [Full Text] [Related]  

  • 27. Convulsions associated with cyclosporin A in renal transplant recipients.
    Beaman M; Parvin S; Veitch PS; Walls J
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):139-40. PubMed ID: 3917716
    [No Abstract]   [Full Text] [Related]  

  • 28. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.
    Turgeon DK; Leichtman AB; Blake DS; Schmouder RL; Lown KS; Annesley TM; Watkins PB
    Transplantation; 1994 Jun; 57(12):1736-41. PubMed ID: 8016878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine in living related and cadaveric renal transplantation.
    Albrechtsen D; Soedal G; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Opedal BR; Rugstad HE; Thorsby E
    Transplant Proc; 1984 Oct; 16(5):1191-4. PubMed ID: 6385375
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclosporine blood level monitoring: the early posttransplant period.
    Ferguson RM; Canafax DM; Sawchuck RT; Simmons RL
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):113-22. PubMed ID: 3515676
    [No Abstract]   [Full Text] [Related]  

  • 31. [Care of kidney transplant patients using different immunosuppressive drugs].
    Yu PP
    Zhonghua Hu Li Za Zhi; 1987 Apr; 22(4):165-6. PubMed ID: 3308152
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive therapy with cyclosporine for cardiac transplantation.
    Kahan BD
    Circulation; 1987 Jan; 75(1):40-56. PubMed ID: 3539397
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of oral and intravenous cyclosporine A in kidney transplants.
    Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine nephrotoxicity can be minimized by careful monitoring of whole blood trough levels.
    Uchida K; Nakanisi N; Yamada N; Tominaga Y; Orihara A; Kondo T; Morimoto T; Morozumi K; Kano T; Takagi H
    Dev Toxicol Environ Sci; 1986; 14():163-6. PubMed ID: 3549249
    [No Abstract]   [Full Text] [Related]  

  • 35. Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness?
    Hakim M; White DJ; Cory-Pearce R; English TA; Wallwork J
    J Heart Transplant; 1985 Feb; 4(2):217-9. PubMed ID: 3916489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rejection and nephrotoxicity. Diagnostic problems with cyclosporine in renal transplantation.
    Pichlmayr R; Wonigeit K; Ringe B; Block T; Raab R; Heigel B; Neuhaus P
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():947-60. PubMed ID: 3887390
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is cyclosporin a welcome addition in kidney transplantation?].
    van Oers MH; ten Veen JH
    Ned Tijdschr Geneeskd; 1984 Jun; 128(22):1058-61. PubMed ID: 6377098
    [No Abstract]   [Full Text] [Related]  

  • 38. The antagonistic effect of rifampin upon cyclosporine bioavailability.
    Van Buren D; Wideman CA; Ried M; Gibbons S; Van Buren CT; Jarowenko M; Flechner SM; Frazier OH; Cooley DA; Kahan BD
    Transplant Proc; 1984 Dec; 16(6):1642-5. PubMed ID: 6390878
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection?
    Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporin A in cadaveric renal transplantation.
    D'Apice AJ
    Med J Aust; 1985 Feb; 142(3):172-4. PubMed ID: 3881653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.